Icon

RILUTEK (nda020599)- (50MG)

RILUZOLE COVIS
50MG
No No
2013-Jun-18 Expired
None None
None No
RILUTEK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
6 0 5
Total Other Developers None
Drugs with Suitability No
50MG ** ** - 5 -
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** *** ***** **** *** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ****** ******** ****. & *****. **., ***. ***** ** *********** **. ***, ******* **., ****** ****, *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.